Literature DB >> 6325444

Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system.

D J Knauer, H S Wiley, D D Cunningham.   

Abstract

Because mitogenic stimulation by epidermal growth factor (EGF) requires at least an 8--12-h exposure to commit the majority of the cells to divide, a number of complicating processes must be evaluated in an analysis of the relationship between receptor occupancy and the biological response. During this period, the number of cellular EGF receptors changes and the cells continuously bind, internalize, and degrade the hormone. To deal with these changes, we utilized our previously described steady state model that permits an analysis of EGF interactions with cells under steady state conditions. For these studies we derived and measured a number of steady state rate constants to describe the interaction of 125I-EGF with cultured human and mouse fibroblast-like cells. The validity of these constants was established by demonstrating the close agreement between experimentally determined results and predicted results from computer simulations using these constants. These approaches in conjunction with experiments on the mitogenic stimulation of the cells with EGF led to the conclusion that there is a linear relationship between mitogenic stimulation and EGF receptor occupancy at steady state, with no apparent "spare" EGF receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325444

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Differential endocytotic characteristics of a novel human B/DC cell line HBM-Noda: effective macropinocytic and phagocytic function rather than scavenging function.

Authors:  I Torii; S Morikawa; M Nagasaki; A Nokano; K Morikawa
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".

Authors:  K E Forsten; D A Lauffenburger
Journal:  Biophys J       Date:  1992-02       Impact factor: 4.033

3.  Mechanical control of spheroid growth: distinct morphogenetic regimes.

Authors:  Oswaldo A Lozoya; Sharon R Lubkin
Journal:  J Biomech       Date:  2011-12-06       Impact factor: 2.712

4.  Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes.

Authors:  A Rami Tzafriri; Elazer R Edelman
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

5.  Deterministic model of dermal wound invasion incorporating receptor-mediated signal transduction and spatial gradient sensing.

Authors:  Jason M Haugh
Journal:  Biophys J       Date:  2006-01-13       Impact factor: 4.033

6.  Mathematical modelling and computational study of two-dimensional and three-dimensional dynamics of receptor-ligand interactions in signalling response mechanisms.

Authors:  Pilar García-Peñarrubia; Juan J Gálvez; Jesús Gálvez
Journal:  J Math Biol       Date:  2013-07-28       Impact factor: 2.259

7.  Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis.

Authors:  E M Wakshull; W Wharton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Kinetics of epidermal growth factor/receptor binding on cells measured by total internal reflection/fluorescence recovery after photobleaching.

Authors:  E H Hellen; D Axelrod
Journal:  J Fluoresc       Date:  1991-06       Impact factor: 2.217

Review 9.  Screening the cellular microenvironment: a role for microfluidics.

Authors:  Jay W Warrick; William L Murphy; David J Beebe
Journal:  IEEE Rev Biomed Eng       Date:  2008-11-05

10.  Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion.

Authors:  K Francis; B O Palsson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.